Diversified Consumer Services
Company Overview of University of Notre Dame
University of Notre Dame is an educational and research institution that offers graduate and postgraduate programs in arts and letters, engineering, business administration, science, architecture, and law. University of Notre Dame was founded in 1842 and is based in Notre Dame, Indiana.
400 Main Building
Notre Dame, IN 46556
Founded in 1842
Key Executives for University of Notre Dame
President of the Native American Students Association of Notre Dame (Nasand)
Executive Vice President and Trustee
Chief of Staff and Special Assistant to the President
Compensation as of Fiscal Year 2015.
University of Notre Dame Key Developments
University of Notre Dame Appoints Paul J. Slaggert as Director of the Stayer Center for Executive Education
Nov 24 15
Paul J. Slaggert has been named the director of the Stayer Center for Executive Education at the University of Notre Dame's Mendoza College of Business. Slaggert, who previously served as the director of Stayer's non-degree programs, will be responsible for the leadership and administrative oversight of marketing, recruiting, student services, curriculum and operations for all of the executive education programs. These include the graduate degree programs the Notre Dame Executive MBA in South Bend and Chicago, the Master of Science in Business Analytics and the Master of Science in Finance as well as non-degree open-enrollment, custom and online programs.
Retrophin, Inc. Announces Research Collaboration with the Grace Wilsey Foundation and the Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame
Nov 5 15
Retrophin, Inc. announced a research collaboration with the Grace Wilsey Foundation and the Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame surrounding the development of a novel therapeutic for patients with NGLY1 deficiency, a rare genetic disorder. NGLY1 deficiency is believed to be caused by a deficiency in an enzyme called N-glycanase-1, which is encoded by the gene NGLY1. The condition is characterized by a variety of symptoms, including global developmental delay, movement disorder, seizures, and ocular abnormalities. Under this collaboration, the Grace Wilsey Foundation will provide support and funding to Retrophin to enable discovery efforts that aim to validate and address a new molecular target that may be relevant to NGLY1 deficiency. In addition, the Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame will also provide funding and in-kind research support to help Retrophin advance this program. The initial research effort will focus on the hypothesis that a specific novel molecular target may compensate for the lack of NGLY1 in affected cells. Retrophin will apply its scientific and drug development capabilities to lead efforts towards the validation of this proposed target.
University of Notre Dame Presents at Managed Funds Association Global Summit 2015, Oct-27-2015 02:00 PM
Sep 24 15
University of Notre Dame Presents at Managed Funds Association Global Summit 2015, Oct-27-2015 02:00 PM. Venue: The May Fair Hotel, London, United Kingdom. Speakers: Sean Mulvehill, Investment Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|